ImmunityBio, Inc.

ImmunityBio, Inc. (IBRX) shows zero cyber incidents and zero red-flag 8-Ks over the past 90 days, indicating no material governance disruptions in the recent window. However, absence of recent events does not equal absence of risk; a 90-day snapshot misses longer-term financing patterns, share dilution trajectories, and structural vulnerabilities that emerge over 12 months. The full $49 Report extends the analysis to a full-year baseline, calculates dilution risk scores, maps financing history, and surfaces AI-detected warning signals invisible in headline filings. The full $49 Report adds quantified dilution exposure, 12-month red-flag context, and predictive risk scoring across capital structure and operational stability.